Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

ABSTRACT:

Importance

Universal screening of patients with newly diagnosed cancer for hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV is not routine in oncology practice, and experts disagree about whether universal screening should be performed.

Objective

To estimate the prevalence of HBV, HCV, and HIV infection among persons with newly diagnosed cancer.

Design, setting, and participants

Multicenter prospective cohort study of patients with newly diagnosed cancer (ie, identified within 120 days of cancer diagnosis) at 9 academic and 9 community oncology institutions affiliated with SWOG (formerly the Southwest Oncology Group) Cancer Research Network, a member of the National Clinical Trials Network, with enrollment from August 29, 2013, through February 15, 2017. The

SUBMITTER: Ramsey SD 

PROVIDER: S-EPMC6459217 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature